Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27266509)

Published in BMC Public Health on June 07, 2016

Authors

Alex Vorsters1, Tine Cornelissen2, Elke Leuridan3, Johannes Bogers4,5,6, Davy Vanden Broeck4,5,6, Ina Benoy4,5, Herman Goossens7,8, Niel Hens9,10,11, Pierre Van Damme3

Author Affiliations

1: Centre for the Evaluation of Vaccination (CEV), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, B 2610, Antwerp, Belgium. alex.vorsters@uantwerpen.be.
2: Antwerp Health House for Prostitution, Ghapro vzw, Antwerp, Belgium.
3: Centre for the Evaluation of Vaccination (CEV), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, B 2610, Antwerp, Belgium.
4: Algemeen Medisch Laboratorium (part of National Reference Centre for HPV), Emiel Vloorsstraat 9, 2020, Antwerp, Belgium.
5: Applied Molecular Biology Research (AMBIOR), University of Antwerp, Antwerp, Belgium.
6: International Centre for Reproductive Health (ICRH), Ghent University, Ghent, Belgium.
7: Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
8: Clinical Microbiology, Antwerp University Hospital, Antwerp, Belgium.
9: Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Hasselt University, Hasselt, Belgium.
10: Centre for Health Economics Research and Modeling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
11: Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium.

Articles cited by this

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis (2007) 6.86

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine (2008) 4.31

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet (1999) 4.24

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006) 4.14

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38

A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine (2012) 3.03

The rational clinical examination. Does this patient have a torn meniscus or ligament of the knee? Value of the physical examination. JAMA (2001) 2.62

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol (2009) 1.48

Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect Dis (2011) 1.45

Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis (2010) 1.35

Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis (2000) 1.29

Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev (2009) 1.08

Cervical smears and human papillomavirus typing in sex workers. Sex Transm Infect (2004) 1.06

High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin Chem Lab Med (2011) 1.01

Cervical HPV Infection in Female Sex Workers: A Global Perspective. Open AIDS J (2013) 0.97

Prior knowledge of HPV status improves detection of CIN2+ by cytology screening. Am J Obstet Gynecol (2011) 0.95

Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis (2014) 0.94

Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium). Vaccine (2011) 0.93

Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses. J Infect Dis (2011) 0.93

Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening. J Clin Microbiol (2012) 0.93

Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories. Acta Cytol (1999) 0.91

Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial. BMC Infect Dis (2013) 0.86

The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populations. Scand J Infect Dis (2004) 0.80

Human papillomavirus infection and cervical dysplasia in female sex workers in Northeast China: an observational study. BMC Public Health (2015) 0.77